Cargando…

Co-design of harm reduction materials for people who inject drugs to implement research findings

BACKGROUND: Equipment used by people who inject drugs (PWID) either has a needle which is fixed to the syringe or can be detached and replaced. Detachable low dead space syringes (LDSS) have been developed, with less space between the needle and plunger (referred to as dead space) than traditional d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussey, Deborah, Trinder-Widdess, Zoe, Dee, Cassie, Bagnall, Darren, Bojangles, Tatty, Kesten, Joanna May
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555749/
https://www.ncbi.nlm.nih.gov/pubmed/31174536
http://dx.doi.org/10.1186/s12954-019-0300-z
_version_ 1783425202857705472
author Hussey, Deborah
Trinder-Widdess, Zoe
Dee, Cassie
Bagnall, Darren
Bojangles, Tatty
Kesten, Joanna May
author_facet Hussey, Deborah
Trinder-Widdess, Zoe
Dee, Cassie
Bagnall, Darren
Bojangles, Tatty
Kesten, Joanna May
author_sort Hussey, Deborah
collection PubMed
description BACKGROUND: Equipment used by people who inject drugs (PWID) either has a needle which is fixed to the syringe or can be detached and replaced. Detachable low dead space syringes (LDSS) have been developed, with less space between the needle and plunger (referred to as dead space) than traditional detachable equipment. This equipment can help protect PWID from harm of infection as less blood is transferred if equipment is shared. Our previous research found that detachable LDSS are likely to be acceptable to PWID, and we produced recommendations for their introduction in needle and syringe programmes (NSP) in the United Kingdom (UK). We held a national stakeholder meeting to discuss how to accelerate the pace and scale of the rollout and uptake of detachable LDSS. This commentary reflects on the involvement of PWID as co-designers of harm reduction materials to implement these research findings in a way that supports the uptake of LDSS equipment by NSP and service users. We present the user-centred design process, peer reflections on the project, and lessons learnt by the team working with the peers. MAIN BODY: Peers and stakeholders translated the research into easy to understand messages following a consultation with NSP across the UK. Working with Linnell Publications over three workshops, peers selected their preferred design style and informed the language, messages, and overall look of the designs. The peers ensured the designs avoided images and language with negative connotations, humour, and unequivocal language. Peers said that they found the process enjoyable and informative—leading to increased awareness of harm reduction practices. The facilitators took steps to ensure the views of the peers were heard throughout. They reflected on the importance of involving PWID meaningfully throughout the project. Without the peers, the designs would be less effective and engaging to their target audience. CONCLUSION: We conclude that placing peers at the heart of this research implementation project was essential to ensure the materials are appropriate and engaging and do not stigmatise or alienate the intended audience unintentionally. We recommend that others planning similar work include peers within the entire project to support their meaningful contribution.
format Online
Article
Text
id pubmed-6555749
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65557492019-06-10 Co-design of harm reduction materials for people who inject drugs to implement research findings Hussey, Deborah Trinder-Widdess, Zoe Dee, Cassie Bagnall, Darren Bojangles, Tatty Kesten, Joanna May Harm Reduct J Commentary BACKGROUND: Equipment used by people who inject drugs (PWID) either has a needle which is fixed to the syringe or can be detached and replaced. Detachable low dead space syringes (LDSS) have been developed, with less space between the needle and plunger (referred to as dead space) than traditional detachable equipment. This equipment can help protect PWID from harm of infection as less blood is transferred if equipment is shared. Our previous research found that detachable LDSS are likely to be acceptable to PWID, and we produced recommendations for their introduction in needle and syringe programmes (NSP) in the United Kingdom (UK). We held a national stakeholder meeting to discuss how to accelerate the pace and scale of the rollout and uptake of detachable LDSS. This commentary reflects on the involvement of PWID as co-designers of harm reduction materials to implement these research findings in a way that supports the uptake of LDSS equipment by NSP and service users. We present the user-centred design process, peer reflections on the project, and lessons learnt by the team working with the peers. MAIN BODY: Peers and stakeholders translated the research into easy to understand messages following a consultation with NSP across the UK. Working with Linnell Publications over three workshops, peers selected their preferred design style and informed the language, messages, and overall look of the designs. The peers ensured the designs avoided images and language with negative connotations, humour, and unequivocal language. Peers said that they found the process enjoyable and informative—leading to increased awareness of harm reduction practices. The facilitators took steps to ensure the views of the peers were heard throughout. They reflected on the importance of involving PWID meaningfully throughout the project. Without the peers, the designs would be less effective and engaging to their target audience. CONCLUSION: We conclude that placing peers at the heart of this research implementation project was essential to ensure the materials are appropriate and engaging and do not stigmatise or alienate the intended audience unintentionally. We recommend that others planning similar work include peers within the entire project to support their meaningful contribution. BioMed Central 2019-06-07 /pmc/articles/PMC6555749/ /pubmed/31174536 http://dx.doi.org/10.1186/s12954-019-0300-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Hussey, Deborah
Trinder-Widdess, Zoe
Dee, Cassie
Bagnall, Darren
Bojangles, Tatty
Kesten, Joanna May
Co-design of harm reduction materials for people who inject drugs to implement research findings
title Co-design of harm reduction materials for people who inject drugs to implement research findings
title_full Co-design of harm reduction materials for people who inject drugs to implement research findings
title_fullStr Co-design of harm reduction materials for people who inject drugs to implement research findings
title_full_unstemmed Co-design of harm reduction materials for people who inject drugs to implement research findings
title_short Co-design of harm reduction materials for people who inject drugs to implement research findings
title_sort co-design of harm reduction materials for people who inject drugs to implement research findings
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555749/
https://www.ncbi.nlm.nih.gov/pubmed/31174536
http://dx.doi.org/10.1186/s12954-019-0300-z
work_keys_str_mv AT husseydeborah codesignofharmreductionmaterialsforpeoplewhoinjectdrugstoimplementresearchfindings
AT trinderwiddesszoe codesignofharmreductionmaterialsforpeoplewhoinjectdrugstoimplementresearchfindings
AT deecassie codesignofharmreductionmaterialsforpeoplewhoinjectdrugstoimplementresearchfindings
AT bagnalldarren codesignofharmreductionmaterialsforpeoplewhoinjectdrugstoimplementresearchfindings
AT bojanglestatty codesignofharmreductionmaterialsforpeoplewhoinjectdrugstoimplementresearchfindings
AT kestenjoannamay codesignofharmreductionmaterialsforpeoplewhoinjectdrugstoimplementresearchfindings